ELENA BELOVA: Open Payments
NPI 1487367561 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 58 payments from 17 companies in 2025. Trend: 2023 $418 · 2024 $1,147 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $251 |
| Janssen Pharmaceuticals, Inc | 5 | $117 |
| ABBVIE INC. | 5 | $111 |
| Alkermes, Inc. | 4 | $109 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $89 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Almatica Pharma LLC | 3 | $49 |
Products named: REXULTI, VRAYLAR, ARISTADA, SPRAVATO, CAPLYTA, Auvelity, TRINTELLIX, AUSTEDO XR.
Industry payments across NV — which companies pay providers there.
